Use of topical medication in orofacial neuropathic pain: a retrospective study

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 105, Issue 4, 2008, Pages 466-469

  Heir, Gary ^a   Karolchek, Scott ^b   Kalladka, Mythili ^a   Vishwanath, Archana ^a   Gomes, Julyana ^a   Khatri, Raashi ^a   Nasri, Cibele ^a   Eliav, Eli ^c   Ananthan, Sowmya ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b Pharmacy Creations   (United States)

^c Department of Diagnostic Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG COMBINATION; EPIDEMIOLOGY; FACE PAIN; FACIAL NERVE DISEASE; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DRUG THERAPY, COMBINATION; EPIDEMIOLOGIC METHODS; FACIAL NERVE DISEASES; FACIAL PAIN; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 40549117874     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2007.09.030     Document Type: Article

References (31)

1. Merskey H., Bogduk N., and International Association for the Study of Pain. IPT, Classification of Chronic Pain. IASP Task Force on Taxonomy. 2nd ed. (1994), IASP Press, Seattle (WA) 209-214
2. Truelove E. Management issues of neuropathic trigeminal pain from a dental perspective. J Orofac Pain 18 4 (2004) 374-380
3. Vickers E.R., and Cousins M.J. Neuropathic orofacial pain, part 1-prevalence and pathophysiology. Aust Endod J 26 1 (2000) 19-26
4. Delcanho R.E. Neuropathic implications of prosthodontic treatment. J Prosthet Dent 73 2 (1995) 146-152
5. Gregg J.M. Neuropathic complications of mandibular implant surgery: review and case presentations. Ann R Australas Coll Dent Surg 15 (2000) 176-180
6. Lewis M.A., Sankar V., De Laat A., and Benoliel R. Management of neuropathic orofacial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 Suppl (2007) S32 e1-24.
7. Watson C.P. Management issues of neuropathic trigeminal pain from a medical perspective. J Orofac Pain 18 4 (2004) 366-373
8. Feinberg S.D. Prescribing analgesics. How to improve function and avoid toxicity when treating chronic pain. Geriatrics 55 11 (2000) 44-62
9. Collins S.D., and Chessell I.P. Emerging therapies for neuropathic pain. Expert Opin Emerg Drugs 10 1 (2005) 95-108
10. Colombo B., Annovazzi P.O., and Comi G. Medications for neuropathic pain: current trends. Neurol Sci 27 Suppl 2 (2006) S183-S189
11. McCleane G. Topical analgesics. Med Clin North Am 91 1 (2007) 125-139
12. Padilla M., Clark G.T., and Merrill R.L. Topical medications for orofacial neuropathic pain: a review. J Am Dent Assoc 131 2 (2000) 184-195
13. Rowbotham M.C., Davies P.S., and Fields H.L. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 37 2 (1995) 246-253
14. Priano L., Gasco M.R., and Mauro A. Transdermal treatment options for neurological disorders: impact on the elderly. Drugs Aging 23 5 (2006) 357-375
15. Giamberardino M.A. Pain 2002: an updated review refresher course syllabus. 10th World Congress on Pain (2002), IASP Press, Seattle (WA)
16. Farrar J.T., Young Jr. J.P., LaMoreaux L., Werth J.L., and Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 2 (2001) 149-158
17. Lund J.P., Dubner R., and Sessle B.J. Orofacial pain: from basic science to clinical management (2001), Quintessence, Chicago LG
18. Lynch M.E., Clark A.J., Sawynok J., and Sullivan M.J. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain 6 10 (2005) 644-649
19. Gilron I., and Max M.B. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother 5 6 (2005) 823-830
20. Jackson II K.C. Pharmacotherapy for neuropathic pain. Pain Pract 6 1 (2006) 27-33
21. Lynch M.E., Clark A.J., and Sawynok J. A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain 19 5 (2003) 323-328
22. Jensen T.S. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain 6 Suppl A (2002) 61-68
23. Covino B.G. Pharmacology of local anesthetic agents. Ration Drug Ther 21 8 (1987) 1-9
24. Kyuki K. [Evaluation of nonsteroidal anti-inflammatory drugs (NSAID) intended for use as topical anti-inflammatory drugs.]. Nippon Yakurigaku Zasshi 79 6 (1982) 461-485 Japanese.
25. Backonja M., Arndt G., Gombar K.A., Check B., and Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 56 1 (1994) 51-57
26. Posner R. Liposomes. J Drugs Dermatol 1 2 (2002) 161-164
27. Mura P., Faucci M.T., Bramanti G., and Corti P. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci 9 4 (2000) 365-372
28. Remane Y., Leopold C.S., and Maibach H.I. Percutaneous penetration of methyl nicotinate from ointments using the laser Doppler technique: bioequivalence and enhancer effects. J Pharmacokinet Pharmacodyn 33 6 (2006) 719-735
29. Shin S.C., and Cho C.W. Enhanced transdermal delivery of pranoprofen from the bioadhesive gels. Arch Pharm Res 29 10 (2006) 928-933
30. Silvander M., Ringstad L., Ghadially R., and Skold T. A new water-based topical carrier with polar skin-lipids. Lipids Health Dis 5 (2006) 12
31. Sawynok J. Topical and peripherally acting analgesics. Pharmacological reviews 55 1 (2003) 1-20